Skip to main content
Top
Published in: Nutrition Journal 1/2014

Open Access 01-12-2014 | Short report

Increased dietary α-linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination of data from a randomised, placebo-controlled, parallel study

Authors: Caroline E Childs, Samantha Kew, Yvonne E Finnegan, Anne M Minihane, Elizabeth C Leigh-Firbank, Christine M Williams, Philip C Calder

Published in: Nutrition Journal | Issue 1/2014

Login to get access

Abstract

Background

There is a metabolic pathway by which mammals can convert the omega-3 (n-3) essential fatty acid α-linolenic acid (ALA) into longer-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). As far as we know there are currently no studies that have specifically examined sex differences in the LC n-3 PUFA response to increased dietary ALA intake in humans, although acute studies with isotope-labelled ALA identified that women have a significantly greater capacity to synthesise EPA and DHA from ALA compared to men.

Findings

Available data from a placebo-controlled, randomised study were re-examined to identify whether there are sex differences in the LC n-3 PUFA response to increased dietary ALA intake in humans. There was a significant difference between sexes in the response to increased dietary ALA, with women having a significantly greater increase in the EPA content of plasma phospholipids (mean +2.0% of total fatty acids) after six months of an ALA-rich diet compared to men (mean +0.7%, P = 0.039). Age and BMI were identified as predictors of response to dietary ALA among women.

Conclusions

Women show a greater increase in circulating EPA than men during increased dietary ALA consumption. Further understanding of individual variation in the response to dietary ALA could inform nutrition advice, with recommendations being specifically tailored according to habitual diet, sex, age and BMI.
Literature
1.
go back to reference Sprecher H: Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta. 2000, 1486: 219-231. 10.1016/S1388-1981(00)00077-9.CrossRefPubMed Sprecher H: Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta. 2000, 1486: 219-231. 10.1016/S1388-1981(00)00077-9.CrossRefPubMed
2.
go back to reference Burdge GC, Jones AE, Wootton SA: Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr. 2002, 88: 355-363. 10.1079/BJN2002662.CrossRefPubMed Burdge GC, Jones AE, Wootton SA: Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr. 2002, 88: 355-363. 10.1079/BJN2002662.CrossRefPubMed
3.
go back to reference Burdge GC, Wootton SA: Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr. 2002, 88: 411-420. 10.1079/BJN2002689.CrossRefPubMed Burdge GC, Wootton SA: Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr. 2002, 88: 411-420. 10.1079/BJN2002689.CrossRefPubMed
4.
go back to reference Lohner S, Fekete K, Marosvolgyi T, Decsi T: Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications. Ann Nutr Metab. 2013, 62: 98-112. 10.1159/000345599.CrossRefPubMed Lohner S, Fekete K, Marosvolgyi T, Decsi T: Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications. Ann Nutr Metab. 2013, 62: 98-112. 10.1159/000345599.CrossRefPubMed
5.
go back to reference Bakewell L, Burdge GC, Calder PC: Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr. 2006, 96: 93-99. 10.1079/BJN20061801.CrossRefPubMed Bakewell L, Burdge GC, Calder PC: Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr. 2006, 96: 93-99. 10.1079/BJN20061801.CrossRefPubMed
6.
go back to reference Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL: Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr. 2004, 80: 1167-1174.PubMed Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL: Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr. 2004, 80: 1167-1174.PubMed
7.
go back to reference Giltay EJ, Duschek EJ, Katan MB, Zock PL, Neele SJ, Netelenbos JC: Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women. J Endocrinol. 2004, 182: 399-408. 10.1677/joe.0.1820399.CrossRefPubMed Giltay EJ, Duschek EJ, Katan MB, Zock PL, Neele SJ, Netelenbos JC: Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women. J Endocrinol. 2004, 182: 399-408. 10.1677/joe.0.1820399.CrossRefPubMed
8.
go back to reference Sumino H, Ichikawa S, Murakami M, Nakamura T, Kanda T, Sakamaki T, Mizunuma H, Kurabayashi M: Effects of hormone replacement therapy on circulating docosahexaenoic acid and eicosapentaenoic acid levels in postmenopausal women. Endocr J. 2003, 50: 51-59. 10.1507/endocrj.50.51.CrossRefPubMed Sumino H, Ichikawa S, Murakami M, Nakamura T, Kanda T, Sakamaki T, Mizunuma H, Kurabayashi M: Effects of hormone replacement therapy on circulating docosahexaenoic acid and eicosapentaenoic acid levels in postmenopausal women. Endocr J. 2003, 50: 51-59. 10.1507/endocrj.50.51.CrossRefPubMed
9.
go back to reference Arterburn LM, Hall EB, Oken H: Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006, 83: 1467S-1476S.PubMed Arterburn LM, Hall EB, Oken H: Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006, 83: 1467S-1476S.PubMed
10.
go back to reference Brenna JT, Salem N, Sinclair AJ, Cunnane SC: alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids. 2009, 80: 85-91. 10.1016/j.plefa.2009.01.004.CrossRefPubMed Brenna JT, Salem N, Sinclair AJ, Cunnane SC: alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids. 2009, 80: 85-91. 10.1016/j.plefa.2009.01.004.CrossRefPubMed
11.
go back to reference Burdge GC, Calder PC: Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective. Nutr Res Rev. 2006, 19: 26-52. 10.1079/NRR2005113.CrossRefPubMed Burdge GC, Calder PC: Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective. Nutr Res Rev. 2006, 19: 26-52. 10.1079/NRR2005113.CrossRefPubMed
12.
go back to reference Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM: Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr. 2003, 77: 783-795.PubMed Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM: Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr. 2003, 77: 783-795.PubMed
13.
go back to reference Scientific Advisory Committee on Nutrition/Committee on Toxicity: Advice on Fish Consumption: Benefits & Risks. 2004, Norwich, UK: TSO Scientific Advisory Committee on Nutrition/Committee on Toxicity: Advice on Fish Consumption: Benefits & Risks. 2004, Norwich, UK: TSO
Metadata
Title
Increased dietary α-linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination of data from a randomised, placebo-controlled, parallel study
Authors
Caroline E Childs
Samantha Kew
Yvonne E Finnegan
Anne M Minihane
Elizabeth C Leigh-Firbank
Christine M Williams
Philip C Calder
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2014
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-13-113

Other articles of this Issue 1/2014

Nutrition Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.